1. Finalists Announced for 2018 Diabetes Innovation Challenge

    Winners of $250,000 in Cash and In-Kind Prizes to be Announced at Live Event in Boston May 21, 2018.  Press Release BOSTON, April 24, 2018 (GLOBE NEWSWIRE) — T1D Exchange, a nonprofit patient-centered research organization dedicated to accelerating novel treatments to improve the lives of people with type 1 diabetes (T1D), today announced that 10 academic […]

    Read More
  2. Nasal Glucagon Proves Effective in Real-World Conditions

    Trial participants also reported that the experimental glucagon was easy to use in the two late-phase trials. -Craig Idlebrook/GluCraig Data from two new studies provide evidence that nasal glucagon could be an effective treatment for hypoglycemia in a real-world setting. The two Phase III studies, funded by Eli Lilly and Locemia Solutions, aimed to gauge whether […]

    Read More
  3. 7 Possible New Ways to Detect Diabetes and Diabetes Complications Early

    By Craig Idlebrook, Glu community manager/GluCraig Voting is now open for the People’s Choice Award, which is part of the T1D Exchange Diabetes Innovation Challenge. The Challenge is a prize competition that seeks to identify the most promising innovations in diabetes care and to award the top innovators with cash and in-kind support. For the […]

    Read More
  4. 5 Possible Artificial Pancreas Ideas for the Future

    You can vote for your favorite new idea for treating diabetes as part of the T1D Exchange Diabetes Innovation Challenge. By Craig Idlebrook, Glu community manager/GluCraig Voting is now open for the People’s Choice Award, which is part of the T1D Exchange Diabetes Innovation Challenge. The Challenge is a prize competition that seeks to identify […]

    Read More
  5. 10 New Potential Tech Tools for People with Diabetes

    You can vote for your favorite new idea for treating diabetes as part of the T1D Exchange Diabetes Innovation Challenge. By Craig Idlebrook, Glu community manager/GluCraig Voting is now open for the People’s Choice Award, which is part of the T1D Exchange Diabetes Innovation Challenge. The Challenge is a prize competition that seeks to identify […]

    Read More
  6. Here are 9 Novel Ideas for Treating Diabetes

    You can vote for your favorite new idea for treating diabetes as part of the T1D Exchange Diabetes Innovation Challenge. By Craig Idlebrook, Glu community manager/GluCraig Voting is now open for the People’s Choice Award, which is part of the T1D Exchange Diabetes Innovation Challenge. The Challenge is a prize competition that seeks to identify […]

    Read More
  7. This is How The Glu Community Use CGMs

    We take a look at data from several daily polls to see how people with type 1 diabetes use a CGM, why they choose to use a CGM, and why they don’t. By Colleen Garey, Data Analyst Coordinator at T1D Exchange/GluColleenG In the past year, several new continuous glucose monitors (CGM) have gained FDA approval […]

    Read More
  8. FDA Panel Recommends Approval of Implantable CGM

    If FDA regulators accept the panel’s unanimous decision, then Senseonic’s Eversense would be the first implantable CGM approved for the U.S. market. -by Craig Idlebrook, Glu community and content manager/GluCraig An FDA advisory panel voted 8 to 0 to recommend approval for Senseonic’s Eversense, an implantable continuous glucose monitor (CGM). If FDA regulators accept the […]

    Read More
  9. “Artificial Pancreas” Clinic CEO Indicted

    Trina Health founder G. Ford Gilbert has been accused by the federal government of conspiring with Alabama lawmakers to get insurance coverage for his company’s unproven treatment. -by Craig Idlebrook, Glu community and content manager/GluCraig The owner of a company that touts a controversial “artificial pancreas” in-clinic treatment has been indicted on charges related to […]

    Read More
  10. FDA Approves Dexcom G6, A Fully Integrated CGM

    Compatible insulin pump systems can adjust insulin delivery based on its readings. Big news for CGM users: The FDA announced today that it has approved the Dexcom G6 continuous glucose monitor system (CGM). From the FDA press release, here are 6 facts to know: It’s the first CGM given formal FDA approval to be be […]

    Read More